MedPath

上海复宏汉霖生物制药有限公司

Ownership
-
Established
2014-06-26
Employees
-
Market Cap
-
Website
http://www.henlius.com/index.aspx

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Rituximab Injection

Product Name
汉利康
Approval Number
国药准字S20190021
Approval Date
Dec 18, 2023
NMPA

Serplulimab Injection

Product Name
汉斯状
Approval Number
国药准字S20220013
Approval Date
Mar 22, 2022
NMPA

Bevacizumab Injection

Product Name
汉贝泰
Approval Number
国药准字S20210048
Approval Date
Nov 30, 2021
NMPA

Trastuzumab Injection

Product Name
汉曲优
Approval Number
国药准字S20217019
Approval Date
Aug 9, 2021
NMPA

Adalimumab Injection

Product Name
汉达远
Approval Number
国药准字S20200026
Approval Date
Dec 2, 2020
NMPA

Trastuzumab Injection

Product Name
汉曲优
Approval Number
国药准字S20200019
Approval Date
Aug 12, 2020
NMPA

Rituximab Injection

Product Name
汉利康
Approval Number
国药准字S20201002
Approval Date
Apr 15, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.